Barrett esophagus with progression to adenocarcinoma in multiple family members with attenuated familial polyposis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

1. Worldwide Impact of Upper Gastrointestinal Disease in Familial Adenomatous Polyposis.Diagnostics (Basel, Switzerland) · 2025
   Review
2. Increased prevalence of Barrett's esophagus in patients with MUTYH-associated polyposis (MAP).Familial cancer · 2020
   Article
3. Barrett's esophagus in the patients with familial adenomatous polyposis.Familial cancer · 2014
   Article
4. Hereditary Factors in Esophageal Adenocarcinoma.Gastrointestinal tumors · 2014
   Review
5. Germline APC Mutation and Familial Barrett Esophagus: Causal or Coincidence?Gastroenterology & hepatology · 2011
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.